Substitution of smokeless tobacco for cigarettes in Buerger's disease does not prevent limb loss

Journal of Vascular Surgery

Volumn 48, Issue 1, 2008, Pages 210-212

  Lawrence, Peter F ^a   Lund, Olivia I ^a   Jimenez, Juan Carlos ^a   Muttalib, Rehan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; FIBRINOLYTIC AGENT; NIFEDIPINE; PENTOXIFYLLINE;

ADULT; ANAMNESIS; ANGIOPLASTY; ANTIBIOTIC THERAPY; ARTICLE; BELOW KNEE AMPUTATION; BUERGER DISEASE; CASE REPORT; CIGARETTE SMOKING; CLINICAL FEATURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FIBRINOLYTIC THERAPY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIMB ISCHEMIA; MALE; OSTEOMYELITIS; PERIPHERAL CIRCULATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN INFLAMMATION; SMOKELESS TOBACCO; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; DISEASE PROGRESSION; HUMANS; MALE; SMOKING CESSATION; THROMBOANGIITIS OBLITERANS; TOBACCO, SMOKELESS;

EID: 45449109201     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.02.007     Document Type: Article

References (13)

1. Sasaki S., Sakuma M., and Yasuda K. Current status of thromboangiitis obliterans (Buerger's disease) in Japan. Int J Cardiol 75 (2000) 175-181
2. Joyce J.W. Buerger's Disease (thromboangiitis obliterans). Rheum Dis Clin North Am 16 (1990) 463-470
3. McKusick V.A., Harris W.S., Otteson O.E., Goodman R.M., Shelley W.M., and Bloodwell R.O. Buerger's Disease: a distinct clinical and pathologic entity. JAMA 181 (1962) 5-12
4. Adar R., Papa M.Z., and Schneiderman J. Thromboangiitis obliterans: an old disease in need of a new look. Int J Cardiol 75 (2000) 167-170
5. Kobayashi M., Ito M., Nakagawa A., Nishikimi N., and Nimura Y. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 29 (1999) 451-458
6. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 136 (1908) 567-580
7. Hatsukami D.K., Lemmonds C., and Tomar S.L. Smokeless tobacco use: harm reduction or induction approach?. Prev Med 38 (2004) 309-317
8. Gupta R., Gurm H., and Bartholomew J.R. Smokeless tobacco and cardiovascular risk. Arch Intern Med 164 (2004) 1845-1849
9. Cohn S.L., and Taylor W.C. Vascular problems of the lower extremity in athletes. Clin Sports Med 9 (1990) 449-470
10. O'Dell J.R., Linder J., Markin R.S., and Moore G.F. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum 30 (1987) 1054-1056
11. Lie J.T. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum 31 (1988) 813-814
12. Council on Scientific Affairs. Health applications of smokeless tobacco use. JAMA 255 (1986) 1038-1044
13. Connoly G.N., Winn D.M., Hecht S.S., Henningfield J.E., Walker B., and Hoffman D. The reemergence of smokeless tobacco. N Eng J Med 314 (1986) 1020-1027